BCL2 and glioma: Hyperphosphorylated Akt correlates with aggressive glioma biology, enhanced temozolomide and radiotherapy resistance, and suppression of apoptosis through inhibition of caspase-9 and stabilisation of anti-apoptotic Bcl-2.